Theranostic nanomedicine for cancer

Nanomedicine

Volumn 3, Issue 2, 2008, Pages 137-140

  Sumer, Baran ^a   Gao, Jinming ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CONTRAST MEDIUM; DOXORUBICIN; DRUG CARRIER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROCARBON; MOLECULAR MARKER; MONOCLONAL ANTIBODY; NANOCOMPOSITE; NANOPARTICLE; PACLITAXEL; TRASTUZUMAB; TUMOR MARKER;

CANCER CELL; CANCER THERAPY; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; DRUG RESPONSE; DRUG TARGETING; EDITORIAL; FEASIBILITY STUDY; HUMAN; MOLECULAR IMAGING; NANOMEDICINE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SENSITIVITY ANALYSIS; TARGET CELL;

DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOPARTICLES; NEOPLASMS;

EID: 42949170904     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/17435889.3.2.137     Document Type: Editorial

References (7)

1. Ferrari M: Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5, 161-171 (2005).
2. Peer D, Karp JM, Hong S, FaroKHzad OC, Margalit R, Langer R: Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760 (2007).
3. Warner S: Diagnostics plus therapy = theranostics. Scientist 18, 38-39 (2004).
4. Arpino G. Gutierrez C, Weiss H et al.: Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy. J Natl Cancer Inst. 99, 694-705 (2007).
5. Jaffer FA, Weissleder R: Molecular imaging in the clinical arena. JAMA 293, 855-862 (2005).
6. Tran TD, Caruthers SD, Hughes M et al.: Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int. J. Nanomedicine 2, 515-526 (2007).
7. Nasongkla N, Bey E, Ren J et al.: Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 6, 2427-2430 (2006).